Direct clinician access throughout your treatment Retatrutide treatment is a comprehensive, next-generation approach designed to support meaningful and sustainable weight loss
The most useful reference point is the US launch pricing
Talk to a clinician and pharmacist about legality, quality controls, and whether theres a genuine medical need
Also published in the New England Journal of Medicine in 2022, the SURMOUNT-1 trial demonstrated that tirzepatide at the 15 mg dose produced an average weight loss of 22.5% of body weight over 72 weeks approaching results typically seen with bariatric surgery (Jastreboff et al., 2022, PMID: 35658024)

InfiniWells line of oral BPC products includes the following variants to support various needs: BPC Rapid Pro capsules (500 mcg): A higher-strength, rapid-release formula for those seeking more immediate, intensive support BPC Delayed Pro capsules (500 mcg): A delayed-release option for a more targeted and sustained release, providing support over an extended period BPC Rapid capsules (250 mcg): A reliable, fast-release option designed for consistent, daily support BPC Delayed capsules (250 mcg): A delayed-release version of the original 250 mcg formula for gradual, sustained benefits BPC-Lx Pro Spray (500 mcg): A high-strength oral spray designed for convenient daily use, offering an alternative delivery format for those seeking consistent, on-the-go support
Gentle stretching and light activitysuch as walking or swimmingpromote blood flow to affected muscles and reduce stiffness without creating additional microtrauma